Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study

Generate:Biomedicines Announces Close of $273M Series C Financing

Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology

EBR Systems' Pivotal SOLVE-CRT Trial Meets Endpoints: Excellent Interim Analysis Results

Generate:Biomedicines and MD Anderson Enter Co-Development and Commercialization Agreement

Sana Biotechnology Announces Preclinical Data Published in Nature Communications

Ring Therapeutics Raises $86.5M in Series C Funding to Create Next Generation Programmable Medicines

Aera Therapeutics Launches with $193 M for the Next Generation of Transformative Genetic Medicines

Tessera Therapeutics Highlights Advancements Across its Gene Writing™ and Delivery Platforms

eFFECTOR Therapeutics Provides Positive Clinical Data Update for Zotatifin